NCT03691337View on ClinicalTrials.gov

Fascia Iliaca Blocks for Total Hip Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

May 15, 2018

Primary Completion Date

November 12, 2019

Study Completion Date

December 4, 2019

Conditions
THA
Interventions
DRUG

Marcaine 0.25 % Injectable Solution

Fascia iliaca block with volume 0.11 mL x subject height

DRUG

Marcaine 0.25 % Injectable Solution

Fascia iliaca block with volume 0.22 mL x subject height

DRUG

Sodium chloride

Fascia iliaca block with volume 0.11 mL x subject height

Trial Locations (1)

B-3600

Ziekenhuis Oost-Limburg, Genk

All Listed Sponsors
lead

New York School of Regional Anesthesia

OTHER

NCT03691337 - Fascia Iliaca Blocks for Total Hip Arthroplasty | Biotech Hunter | Biotech Hunter